Low Concordance between Gene Expression Signatures in ER Positive HER2 Negative Breast Carcinoma Could Impair Their Clinical Application

• Enora Laas,

  Affiliations Institut Curie, Department of Surgery, Paris, France, Hopital Tenon, Department of Gynaecologic Surgery, Paris, France

  ⨯
• Peter Mallon,

  Affiliations Institut Curie, Department of Surgery, Paris, France, Craigavon Area Hospital Breast Unit, Portadown Northern Ireland, BT63 5QQ

  ⨯
• Francois P. Duhoux,

  Affiliations Institut Curie, Department of Medical Oncology, Paris, France, Centre du Cancer, Cliniques universitaires Saint-Luc, Université catholique de Louvain, B-1200 Brussels, Belgium

  ⨯
• Amina Hamidouche,

  Affiliation Institut Curie, Department of Surgery, Paris, France

  ⨯
• Roman Rouzier,

  Affiliation Institut Curie, Department of Surgery, Paris, France

  ⨯
• Fabien Reyal

  * E-mail: fabien.reyal@curie.fr

  Affiliations Institut Curie, Department of Surgery, Paris, France, Hopital Tenon, Department of Gynaecologic Surgery, Paris, France, Institut Curie, Department of Medical Oncology, Paris, France, Centre du Cancer, Cliniques universitaires Saint-Luc, Université catholique de Louvain, B-1200 Brussels, Belgium, Institut Curie, Translational Research Department, Residual Tumor and Response to Treatment, RT2Lab, Paris, France, Institut Curie, UMR932, Immunity and Cancer, Paris, France

  ⨯